STAT3 and non-small cell lung carcinoma: NCT-80 has broad and potent antitumor effects on both CSCs and non-CSCs in NSCLC in vitro and in vivo without overt toxicity and compensatory activation of the STAT3 and Wnt/β-catenin pathway.